SCHEMBL993144

SCHEMBL993144

COCC(NC(C)=O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.57
KDM4E B2RXH2 1/20 0.57
THRB P10828 1/20 0.57
ALOX15 P16050 1/20 0.57
NFKB1 P19838 1/20 0.57
PTGS2 P35354 1/20 0.57
THPO P40225 1/20 0.57
RECQL P46063 1/20 0.57
BLM P54132 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ALDH1A1 P00352 2/20 0.55
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CACNA1C Q13936 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694958 1.00 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL526519 1.00 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL2323000 0.86 MAPT (0.52) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL15423894 0.84 CA12 (0.51) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL14971060 0.84 TGFBR1 (0.44) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL468784 0.83 SMN1; SMN2 (0.53) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL16104702 0.83 CA12 (0.51) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL527416 0.83 CA12 (0.50) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL1293468 0.83 TGFBR1 (0.42) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL754070 0.83 TGFBR1 (0.42) MAPTKDM4ETHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105523957-B The method that one kettle way prepares scheme for lacosamide 齐鲁天和惠世制药有限公司 2017-10-31 CN claimed
CN-105523957-A Method for preparing Lacosamide by one-pot method QILU TIANHE PHARMACEUTICAL CO LTD 2016-04-27 CN claimed
EP-2621893-A1 PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB Pharma GmbH (DE) 2013-08-07 EP claimed
US-20130190533-A1 PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB PHARMA GMBH (DE) 2013-07-25 US claimed
US-20130041180-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES PRIVATE LIMITED (IN) 2013-02-14 US claimed
EP-2534127-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN Laboratories Limited (IN) 2012-12-19 EP claimed
WO-2012041986-A1 PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB PHARMA GMBH (DE) 2012-04-05 WO claimed
WO-2011099033-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES LIMITED (IN) 2011-08-18 WO claimed
US-9790170-B2 Method for preparing lacosamide ST PHARM CO., LTD. (KR) 2017-10-17 US disclosed
US-9630908-B2 Process for preparing lacosamide UCB PHARMA GMBH (DE) 2017-04-25 US disclosed
US-9630908-B2 Process for preparing lacosamide UCB PHARMA GMBH (DE) 2017-04-25 US disclosed
US-9630908-B2 Process for preparing lacosamide UCB PHARMA GMBH (DE) 2017-04-25 US disclosed
US-20160332958-A1 METHOD FOR PREPARING LACOSAMIDE ST PHARM CO., LTD. (KR) 2016-11-17 US disclosed
EP-3067344-A1 METHOD FOR PREPARING LACOSAMIDE ST Pharm Co. Ltd. (KR) 2016-09-14 EP disclosed
US-20110021482-A1 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE 2011-01-27 US disclosed
EP-2262764-A2 NOVEL N-BENZYLAMIDE SUBSTITUTED DERIVATIVES OF 2-(ACYLAMIDO)ACETIC ACID AND 2-(ACYLAMIDO)PROPIONIC ACIDS: POTENT NEUROLOGICAL AGENTS The University of North Carolina At Chapel Hill (US) 2010-12-22 EP disclosed
WO-2010052011-A1 NOVEL PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB PHARMA, S.A. (BE) 2010-05-14 WO disclosed
WO-2010052011-A1 NOVEL PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB PHARMA, S.A. (BE) 2010-05-14 WO disclosed
WO-2009145816-A2 NOVEL N-BENZYLAMIDE SUBSTITUTED DERIVATIVES OF 2-(ACYLAMIDO)ACETIC ACID AND 2-(ACYLAMIDO)PROPIONIC ACIDS: POTENT NEUROLOGICAL AGENTS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-12-03 WO disclosed
CN-86107574-A Compositions containing penem or carbapenem antibiotics and their use 1987-05-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021482-A1 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents NAAA, AADAC, GBA1 MAPT 241/4885KDM4E 3304/4885THRB 2680/4885
US-20130190533-A1 PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES BCAT2, BCAT1, HNMT MAPT 1547/4885KDM4E 1214/4885THRB 2308/4885
US-20160332958-A1 METHOD FOR PREPARING LACOSAMIDE SPTSSB, DLST, DNPEP MAPT 1837/4885KDM4E 1260/4885THRB 3303/4885
US-20130041180-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE AMY1A, PTMA, NAAA MAPT 3463/4885KDM4E 2800/4885THRB 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.